The 27 analysts offering 12-month price forecasts for Biogen Inc have a median target of 330.00, with a high estimate of 436.00 and a low estimate of 269.00. The median estimate represents a +28.40% increase from the last price of 257.01.
The current consensus among 35 polled investment analysts is to Buy stock in Biogen Inc. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $4.07
Reporting Date Oct 24
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.